Expansion of clinical capacity to address growing market demand Site status now ‘ready for media fill’ N...
Cognizant is set to acquire TQS Integration, a privately owned global industrial data and intelligence company based in ...
Metabolic activators were found to reduce recovery time by as many as 3.5 days in patients with mild-to-moderate Covid-1...
Terumo Europe and University Medical Center Utrecht (UMC Utrecht) have announced that they signed a Memorandum of Unders...
In conjunction with the IAS Conference on HIV Science, Germany's Frontier Biotechnologies has announced positive top-lin...
The United Kingdom (UK) government aims to accelerate the delivery of novel innovations at patient care through the ...
Japan's NEC Corporation announced the development of an AI technology for supporting doctors in determining if colorecta...
Anticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, announced the appointment of...
British Columbia-based PAI Health launched a 12-month pilot program with Zurich Brazil, a regional subsidiary ...
Paris-based Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, ...
QuantuMDx Group Limited, a UK-based developer of transformational point-of-care diagnostics, announces the launch of Q-P...
UK government announced on July 8, 2021, that a new drugs unit will be set up to help end illegal drug-related illness a...
German firm QIAGEN has launched the Workflow Configurator, enabling researchers in the life sciences to easily and quick...
DrAnsay.com, the market leader for online doctor attests, is offering online test certificates for self-applied rapid an...
Hong Kong-based Mobile Gene Biotechnology Co., Ltd. has recently completed the acquisition of MC Diagnos...
Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector produ...
German firm Merck has announced the topping-out ceremony for its new Biotech Development Center in Corsier-sur-Vevey, Sw...
The European Commission has granted marketing authorization for Jardiance®(empagliflozin) as a treatment for adults ...
